In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...
The AHA scientific statement calls for a life-course approach to brain health that integrates cognitive, emotional, ...
A study conducted on an animal model by researchers at the Federal University of São Paulo (UNIFESP) in Brazil demonstrated ...
Best of both modalities” approach combines the efficacy, safety and scalability of RNA therapeutics with the multi-year durability of gene ...
Sapient, a leader in multi-omics data generation for biomarker discovery and clinical insight delivery, has announced the ...
Laguna Biotherapeutics, Inc. (Laguna), a clinical-stage biotechnology company focused on novel live bacterial therapeutics, ...
Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
Proxygen Expands Platform Beyond Degradation to Build Next-Generation Induced Proximity Therapeutics
Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a biotechnology company pioneering ...
Frontiers has announced a new research initiative focusing on weight-bearing CT (WBCT) and functional 3D imaging in orthopedic surgery, aiming to explore their clinical and technological trajectory.
Lower extremity orthopedic disorders, particularly degenerative diseases and related deformities, are a leading cause of pain and disability worldwide, ...
Your Pilates instructor has a deep understanding of the core and how it works. In fact, many instructors complete more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results